1011 – 1020 of 1570
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor alpha Therapies Does the Risk Change With the Time Since Start of Treatment?
(
- Contribution to journal › Article
-
Mark
Distinct Temporal Evolution of TLR-mediated Dendritic Cell Cytokine Secretion in Patients with Limitied and Diffuse Cutaneous Systemic Sclerosis
2009) 9th Annual Meeting of the Federation-of-Clinical-Immunology-Societies In Clinical Immunology 131. p.153-154(
- Contribution to journal › Published meeting abstract
-
Mark
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype
(
- Contribution to journal › Article
-
Mark
Limitations of Antinuclear Antibody Tests (HEp-2) Are Overcome with the Autoimmune Target Test (IT-1) in Systemic Lupus Erythematosus Reply
(
- Contribution to journal › Letter
-
Mark
The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGF beta and IFN gamma Distinguishes Different SSc Clinical Phenotypes
2009) 9th Annual Meeting of the Federation-of-Clinical-Immunology-Societies In Clinical Immunology 131. p.124-125(
- Contribution to journal › Published meeting abstract
-
Mark
Very Early Intervention Is Crucial to Improve Work Outcome in Patients with Rheumatoid Arthritis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Geriatric rheumatoid arthritis patients on delayed anti-TF-alpha agents have higher disease activity and experience more often serious adverse events compared to younger adults
(
- Contribution to journal › Published meeting abstract
-
Mark
Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data
(
- Contribution to journal › Article
-
Mark
Studies of mechanisms underlying the prolonged neutrophil survival in ANCA-associated systemic vasculitis
(
- Contribution to journal › Published meeting abstract
-
Mark
From aggrecan to matrix
2009) Annual General Meeting of the British-Society-for-Matrix-Biology In International Journal of Experimental Pathology 90(2). p.93-93(
- Contribution to journal › Published meeting abstract